Clinical trial
A New Active Vitamin D, ED-71 for Osteoporosis
NCT00144456 · Chugai Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00144456 |
|---|---|
| Title | A New Active Vitamin D, ED-71 for Osteoporosis |
| Official title | A Prospective, Randomized, Double-blind Study to Compare the Effect of ED-71 With That of Alfacalcidol on Fracture Incidence in Osteoporotic Patients |
| Lead sponsor | Chugai Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | ED-71, Alfacalcidol, ED-71 placebo, Alfacalcidol placebo |
| Enrollment | 1,056 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Aug 9, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: